ED
BBY icon

Exane Derivatives’s Best Buy BBY Stock Holding History

Exane Derivatives’s Portfolio BBY Stock Details BBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-8
Closed -$727 – 801
2022
Q1 		$727 Hold
8
– – ﹤0.01% 835
2021
Q4 		$813 Sell
8
-53
-87% -$6.03K ﹤0.01% 726
2021
Q3 		$6.45K Sell
61
-625
-91% -$70.2K ﹤0.01% 721
2021
Q2 		$75.4K Buy
+686
New +$80.1K 0.02% 576
2020
Q4 		– Sell
-9,507
Closed -$1.06M – 833
2020
Q3 		$1.06M Sell
9,507
-15,576
-62% -$1.59M 0.31% 75
2020
Q2 		$2.19M Sell
25,083
-11,840
-32% -$898K 0.59% 44
2020
Q1 		$2.1M Sell
36,923
-5,595
-13% -$444K 0.59% 41
2019
Q4 		$3.78M Buy
42,518
+2,814
+7% +$215K 0.7% 36
2019
Q3 		$2.74M Sell
39,704
-1,586
-4% -$111K 0.49% 58
2019
Q2 		$2.88M Buy
+41,290
New +$2.88M 0.5% 61
2018
Q4 		– Sell
-1,154
Closed -$91.6K – 678
2018
Q3 		$91.6K Sell
1,154
-16,061
-93% -$1.24M 0.02% 330
2018
Q2 		$1.28M Sell
17,215
-13,616
-44% -$1.01M 0.21% 98
2018
Q1 		$2.11M Buy
30,831
+18,325
+147% +$1.32M 0.42% 62
2017
Q4 		$856K Buy
12,506
+10,561
+543% +$625K 0.15% 110
2017
Q3 		$111K Sell
1,945
-608
-24% -$34.8K 0.02% 245
2017
Q2 		$146K Buy
2,553
+1,010
+65% +$54K 0.03% 228
2017
Q1 		$75.8K Buy
1,543
+1,280
+487% +$57.2K 0.02% 243
2016
Q4 		$11.2K Sell
263
-235
-47% -$9.98K ﹤0.01% 392
2016
Q3 		$19K Buy
+498
New +$17.5K ﹤0.01% 367
2016
Q2 		– Sell
-43,664
Closed -$1.42M – 557
2016
Q1 		$1.42M Buy
+43,664
New +$1.32M 0.19% 73
2015
Q4 		– Sell
-27,913
Closed -$1.04M – 526
2015
Q3 		$1.04M Buy
+27,913
New +$956K 0.13% 88
2015
Q2 		– Sell
-20,394
Closed -$771K – 526
2015
Q1 		$771K Buy
20,394
+15,546
+321% +$595K 0.09% 111
2014
Q4 		$189K Buy
+4,848
New +$170K 0.03% 222

Other funds holding BBY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Exane Derivatives's BBY Position: Q2 2022 in Review

Exane Derivatives sold out of Best Buy (BBY) in Q2 2022, closing a stake of 8 shares — an estimated $727 sold.

Exane Derivatives first reported a position in BBY in Q4 2014 and held it in 23 quarters. The position peaked at $3.78M in Q4 2019. 767 funds tracked by Wall St. Rank hold BBY as of Q2 2022.

  • Exane Derivatives reported no remaining Best Buy position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 8 Best Buy shares in Q2 2022, an estimated $727.
  • Exane Derivatives first reported a position in Best Buy in Q4 2014 and held it in 23 quarters.
  • Exane Derivatives's Best Buy position peaked at $3.78M in Q4 2019.
  • 767 funds tracked by Wall St. Rank held Best Buy as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.